Skip to content

The Effect of Time-Restricted Eating on Arterial Stiffness Indices in Patients with Metabolic Syndrome

The Effect of Time-Restricted Eating versus Standard Dietary Advice on Arterial Stiffness Indices in Men with Metabolic Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201230049889N1
Enrollment
48
Registered
2022-08-14
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Metabolic syndrome. Condition 2: Arterial stiffness indices. Condition 3: Time-restricted eating. Metabolic syndrome

Interventions

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Men between the ages of 18 and 65 Body mass index (BMI) below 35 Diagnosis of metabolic syndrome according to the International Diabetes Federation (IDF) definition Willingness to participate in the study by signing the informed consent form

Exclusion criteria

Exclusion criteria: Diabetes Thyroid disorders based on thyroid tests or thyroxine use Eating disorders Serious diseases that affect food intake, such as cancer Using supplements that contain compounds other than vitamins and minerals Inability to follow time-restricted eating diet Specific work and sleep schedule The duration of receiving daily food less than 14 hours

Design outcomes

Primary

MeasureTime frame
Pulse wave velocity (PWV). Timepoint: At the beginning of the study and after 6 weeks from the start of the study. Method of measurement: Pulse Wave Velocity device.

Secondary

MeasureTime frame
Appetite status. Timepoint: At the beginning of the study and 6 weeks after the start of the study. Method of measurement: Visual Analog Scale (VAS).;Physical activity. Timepoint: 3 days at the beginning of the study and 3 days at the end of the study. Method of measurement: Pedometer.;Sleep status. Timepoint: At the beginning of the study and 6 weeks after the start of the study. Method of measurement: Pitssburg Questionnaire.;Quality of life. Timepoint: At the beginning of the study and 6 weeks after the start of the study. Method of measurement: Short form of World Health Organization quality of life questionnaire (WHOQOL-BREF).;Dietary intake. Timepoint: At the beginning of the study and 3 weeks and 6 weeks after the start of the study. Method of measurement: 3-day 24-hour recall.;Body weight. Timepoint: At the beginning of the study and 3 weeks and 6 weeks after the start of the study. Method of measurement: Scales.;Waist circumference. Timepoint: At the beginning of the study and 6 weeks after the start of the study. Method of measurement: Meter.;Body composition. Timepoint: At the beginning of the study and 6 weeks after the start of the study. Method of measurement: Bioelectric Impedance Analysis (BIA) device.;Complete blood count (CBC). Timepoint: At the beginning of the study (fasting and 120 minutes after a meal) and 6 weeks after the start of the study. Method of measurement: Biochemical analysis of blood sample.;Alanine transaminase (ALT). Timepoint: At the beginning of the study and 6 weeks after the start of the study. Method of measurement: Biochemical analysis of blood sample.;Aspartate transaminase (AST). Timepoint: At the beginning of the study and 6 weeks after the start of the study. Method of measurement: Biochemical analysis of blood sample.;C-Reactive Protein (CRP). Timepoint: At the beginning of the study (fasting and 120 minutes after a meal) and 6 weeks after the start of the study. Method of measurement: Biochemical analysis of blood samp

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAliyeh Ghannadzadeh Yazdi

Mashhad University of Medical Sciences

GhannadzadehYA981@mums.ac.ir+98 51 3882 7034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026